BioInvent Implements a Directed New Share Issue Worth SEK 125 Million

The purpose of the resolution to issue new shares is to widen the institutional ownership in BioInvent and to strengthen the Company´s financial position, thus ensuring continued development and increase in value of the project portfolio. The infusion of capital will primarily be used to finance the continued development of the Company´s existing projects. The intention is also to strengthen BioInvent´s position in ongoing and future discussions with potential partners, thus giving the Company a greater freedom to decide at which point in time possible alliances shall be sought with established pharmaceutical companies. This increases the Company´s possibility to maximize the potential value in the project portfolio.